Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / Companies / LIB Therapeutics
Entity

LIB Therapeutics

Tracked across 1 events · 8 articles · First seen Jun 26, 2026 · Last active Jun 26, 2026

Sentiment
0
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
6 0
Regulatory
China NMPA Accepts LEROCHOL BLA
Impact: LIB Therapeutics is the developer of Lerociclib, a novel therapy aimed at helping patients achieve their LDL-C goals.
Jun 26, 2026 · 8 articles
ERGEN INTELLIGENCE
Track LIB Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.